MasandP.S., TesarG.E.Use of stimulants in the medically ill. Psychiatric Clin North Am1996; 19: 515–547.
2.
HomsiJ., WalshD., NelsonK.Psychostimulants in supportive care. Support Care Cancer2000; 8: 385–397.
3.
FriersonR.L., WeyJ.J., TablerJ.B.Psychostimulants for depression in the medically ill. Am Fam Physician1991; 43: 163–170.
4.
DeinS.The use of psychostimulants by palliative care consultants in the UK: a retrospective telephone survey. Palliat Med [in press].
5.
FernandezF., AdamsF., HolmesV.F., LevyJ.K., NeidhartM.Methylphenidate for depressive disorders in cancer patients. Psychosomatics.1987; 28: 455–461.
6.
StiebelV., KempK.Long-term methylphenidate use in the medically ill patient with organic mood syndrome. Psychosomatics1990; 31: 454–456.
7.
BreitbartW., MermelsteinH.Pemoline: an alternative psychostimulant for the management of depressive disorders in cancer patients. Psychosomatics1992; 33: 352–356.
8.
BurnsM., EisendrathS.Dextroamphetamine treatment for depression in terminally ill patients. Psychosomatics1994; 35(1): 80–82.
9.
OlinJ., MasandP.S.Psychostimulants for depression in hospitalized cancer patients. Psychosomatics1996; 37: 57–62.
10.
MacleodA.Methylphenidate in terminal depression. J Pain Symptom Manage1998; 16: 193–198.
11.
HolmesV.F., FernandezF., LevyJ.K.Psychostimulant response in AIDS related complex patients. J Clin Psychiatry198950: 5–8.
12.
FernandezF., LevyJ.K.Psychopharmacotherapy of psychiatric syndromes in asymptomatic and symptomatic HIV infection. Psychiatr Med1991; 9: 377–394.
13.
WagnerG.J., RabkinR.Effects of dextroamphetamine on depression and fatigue in men with HIV: a double blind placebo-controlled trial. J Clin Psychiatry200061: 436–440.
14.
WhiteJ.C., ChristensenJ.F., SingerC.M.Methylphenidate as a treatment for depression in acquired immunodeficiency syndrome: an n-of-1 trial. J Clin Psychiatry1992; 53: 153–156.
15.
AngristB., d'HollosyM., SanfilipoM., SatrianoJ., DiamondG., SimberkoffM., WeinrebH.Central nervous system stimulants as symptomatic treatments for AIDS-related neuropsychiatric impairment. J Clin Psychopharmacol1992; 12: 268–272.
16.
BreitbartW., PassikS.Psychological and psychiatric interventions in pain control. In: DoyleD., HanksG.W.C., MacDonaldN. (eds). Oxford Textbook of Palliative Medicine.New York: Oxford University Press, 1993; p. 253.
17.
BrueraE., MillerM., MacmillanK., KuehnN.Neuropsychological effects of methylphenidate in patients receiving a continuous infusion of narcotics for cancer pain. Pain199248: 163–166.
18.
StiefelF., BrueraE.Psychostimulants for hypoactive hypoalert delirium?J Palliat Care1991; 3: 25–26.
19.
MoritaT., OtaniH., TsumodaJ.Successful palliation of hypoactive delirium due to multi-organ failure by oral methylphenidate. Support Care Cancer2000; 8: 134–137.
20.
BrueraE., ChadwickS.Methylphenidate associated with narcotics for the treatment of cancer pain. Cancer Treat Rep1987; 71: 67–70.
21.
KreegerL., DuncanA., CowapJ.Psychostimulants used for opioid induced drowsiness [letter]. J Pain Symptom Manage1996; 11: 1–2.
22.
WilwerdingM., LoprinziC., MailliardJ., O'FallonJ.R., MiserA.W., van HaelstC.A randomized crossover evaluation of methylphenidate in cancer patients receiving strong narcotics. Support Care Cancer1995; 3: 135–138.
23.
SarhillN., WalshD., NelsonK., HomsiJ., Le GrandS., DavisM.P.Methylphenidate for fatigue in advanced cancer: a prospective open-label pilot study. Am J Hosp Palliat Care2001; 18(3): 187–192.
24.
MeyersC., WeltzmerM., ValentineA., LevinV.A.Methylphenidate therapy improves cognition, mood, and function of brain tumour patients. J Clin Oncol1998; 16: 2522–2527.
25.
BrueraE., FainsingerR., MacEachernT., HansonJ.The use of methylphenidate in patients with incident cancer pain receiving regular opiates: a preliminary report. Pain1992; 50: 75–77.
26.
MasandP., PickettP., MurrayG.B.Psychostimulants for secondary depression in medical illness. Psychosomatics1991; 32: 203–208.
27.
KruppL., CoyleP., DoscherC., MillerA., CrossA.H., JandorfL.Fatigue therapy in multiple sclerosis: results of a double blind, randomized, parallel trial of amantidine, pemoline, and placebo. Neurology1995; 45(11): 1956–1961.
